We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Elan, Mayo Settle Patent Dispute Over Transgenic Mouse

Law360 (November 12, 2004, 12:00 AM EST) -- Irish drug maker Elan Corporation, PLC and the U.S.-based Mayo Foundation for Medical Education and Research have settled their long-running patent dispute over a type of mouse used in research on Alzheimer's disease.

The settlement agreement resolves a patent dispute regarding certain transgenic mice patents and facilitates use by both parties of an array of research tools in combating the disease, Elan and Mayo said in a joint statement.

“The resolution of this dispute provides Mayo and Elan with cross-licenses necessary to pursue their respective ongoing...
To view the full article, register now.